texas oncology more breakthroughs. more victories

Share:

 
 

Habte Yimer, MD, Regarding the POLLUX and CASTOR Studies Presented at ASH 2018

Publication: Oncology Business Review
12/14/2018

Habte Yimer, hematologist and medical oncologist with Texas Oncology–Tyler, offers opinion on how the POLLUX and CASTOR studies shape thinking regarding the use of daratumumab for multiple myeloma patients.
Click here to watch the full story.

Related Physicians

Related Cancer Centers